Merimepodib 2mg | 99.7%
APEXBIO TECHNOLOGY LLC
Novel noncompetitive inhibitor of IMPDH(Inosine monophosphate dehydrogenase). Microbiology & Virology|HBV
More Information Supplier PageMerimepodib
Search Results
Merimepodib 5mg | 99.7%
APEXBIO TECHNOLOGY LLC
Novel noncompetitive inhibitor of IMPDH(Inosine monophosphate dehydrogenase). Microbiology & Virology|HBV
More Information Supplier PageMerimepodib
Merimepodib 10mg | 99.7%
APEXBIO TECHNOLOGY LLC
Novel noncompetitive inhibitor of IMPDH(Inosine monophosphate dehydrogenase). Microbiology & Virology|HBV
More Information Supplier PageMerimepodib
Merimepodib 50mg | 99.7%
APEXBIO TECHNOLOGY LLC
Novel noncompetitive inhibitor of IMPDH(Inosine monophosphate dehydrogenase). Microbiology & Virology|HBV
More Information Supplier PageMerimepodib
N6022 100mg | 99.52%
APEXBIO TECHNOLOGY LLC
N6022
N6022 25mg | 99.52%
APEXBIO TECHNOLOGY LLC
N6022
N6022 5mg | 99.52%
APEXBIO TECHNOLOGY LLC
N6022
N6022 10mM (in 1mL DMSO) | 99.52%
APEXBIO TECHNOLOGY LLC
N6022
VRT752271 100mg | 99.6%
APEXBIO TECHNOLOGY LLC
VRT752271
AZD-9291 mesylate 100mg | 99.48%
APEXBIO TECHNOLOGY LLC
third generation EGFRm inhibitor, oral and irreversible JAK/STAT Signaling|EGFR
More Information Supplier PageAZD-9291 mesylate